Assuntos
Antibacterianos/uso terapêutico , Endocardite Bacteriana/prevenção & controle , Pré-Medicação , American Hospital Association , Ampicilina/uso terapêutico , Antibacterianos/administração & dosagem , Procedimentos Cirúrgicos Cardíacos , Dentística Operatória , Feminino , Gastroenteropatias/terapia , Doenças dos Genitais Femininos/terapia , Doenças dos Genitais Masculinos/terapia , Gentamicinas/uso terapêutico , Humanos , Masculino , Penicilina V/uso terapêutico , Complicações Pós-Operatórias/prevenção & controle , Doenças Respiratórias/cirurgia , Risco , Sepse/prevenção & controle , Estados Unidos , Vancomicina/uso terapêuticoAssuntos
Imunização , Programas Nacionais de Saúde , Poliomielite/prevenção & controle , Rubéola (Sarampo Alemão)/prevenção & controle , Humanos , Esquemas de Imunização , Formulação de Políticas , Vacina Antipólio de Vírus Inativado/administração & dosagem , Vacina Antipólio Oral/administração & dosagem , Vacina contra Rubéola/administração & dosagem , Estados Unidos , VacinaçãoAssuntos
Endocardite Bacteriana/prevenção & controle , Política Pública , Febre Reumática/prevenção & controle , Adulto , American Heart Association , Pré-Escolar , Humanos , Infecções Respiratórias/tratamento farmacológico , Cardiopatia Reumática/prevenção & controle , Infecções Estreptocócicas/tratamento farmacológico , Streptococcus pyogenes , Estados UnidosAssuntos
Endocardite Bacteriana/prevenção & controle , Cardiopatia Reumática/prevenção & controle , American Heart Association , Antibacterianos/uso terapêutico , Procedimentos Cirúrgicos Cardíacos/normas , Assistência Odontológica/normas , Procedimentos Cirúrgicos do Sistema Digestório , Próteses Valvulares Cardíacas , Humanos , Complicações Pós-Operatórias , Risco , Cirurgia Bucal/normas , Estados Unidos , Sistema Urogenital/cirurgiaRESUMO
Eleven 4-13 year old schoolgirls, who were seronegative by haemagglutination inhibition (HI) and radioimmunoassay (RIA) tests despite having been given HPV77-DE5 vaccine 3-9 years previously, were revaccinated with RA27/3. They showed evidence of residual immunity since they had accelerated immune responses, little or no rubella-specific IgM, no viraemia, and no vaccine-induced reactions. In contrast, all but one of the five adult women who were primary vaccinees showed a more delayed immune response. Three of four women tested had viraemia and two had vaccine-induced reactions. Enhanced HI and enhanced RIA showed that many of the schoolgirls had antibody before challenge, as did a fifth adult, who also showed an accelerated immune response, yet became viraemic.
Assuntos
Anticorpos Antivirais/análise , Imunização Secundária , Vírus da Rubéola/imunologia , Rubéola (Sarampo Alemão)/imunologia , Vacinação , Viremia/imunologia , Adolescente , Adulto , Criança , Pré-Escolar , Feminino , Humanos , Imunoglobulina M/análise , Rubéola (Sarampo Alemão)/prevenção & controle , Vacinação/efeitos adversos , Viremia/etiologiaRESUMO
One hundred sixty-eight children immunized by one suburban Minneapolis clinic during routine pediatric visits had serum antibodies measured to determine the efficacy of rubella (HPV77 DE5 strain), measles (Edmonston B and Moraten strains), and mumps (Jeryl Lynn strain) vaccines. Serologic failure rates at the mean postvaccination times tested were as follows: rubella, 36% (4.7 years); measles, 18% (6.5 years); and mumps, 9% (4.5 years). Antibody titers shortly after vaccination were not done, so seronegative subjects may never have responded or their titers may have declined with time; our rubella data suggest the former. Children vaccinated with rubella and measles at less than 14 months of age had higher failure rates than those vaccinated at a later age. This supports postponement of rubella and measles vaccinations until at least 15 months of age. In addition to current measles reimmunization policies, consideration also should be given to reimmunizing girls who were given rubella vaccine at less than 14 months of age. Twenty-four percent (19/79) of children vaccinated with HPV77 DE5 strain rubella at 14 months or older had rubella hemagglutination-inhibiting titers less than 8. This is disturbing and, if confirmed by others, would prompt the use of a different strain of rubella vaccine for routine immunization.